Cyrusone (CONE) Earnings
|
Expand Research on CONE
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -335.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/16/22 | Q421 | -$0.06 | $0.03 | -$0.09 | $318.4M | $304.56M | N/A | ![]() | ![]() | Details | |
| 10/27/21 | Q321 | $1.02 | N/A | N/A | $304.1M | $289.86M | = | ![]() | ![]() | Details | |
| 7/28/21 | Q221 | $1.00 | N/A | N/A | $284.6M | $276.04M | = | ![]() | ![]() | Details | |
| 4/28/21 | Q121 | $1.00 | N/A | N/A | $298.6M | $271.4M | = | ![]() | ![]() | Details | |
| 2/17/21 | Q420 | $0.94 | N/A | N/A | $268.4M | $264.79M | = | ![]() | ![]() | Details | |
| 10/28/20 | Q320 | $0.96 | N/A | N/A | $262.8M | $261.25M | = | ![]() | ![]() | Details | |
| 7/29/20 | Q220 | $1.03 | $0.94 | +$0.09 | $256.4M | $251.78M | = | ![]() | ![]() | Details | |
| 4/29/20 | Q120 | $0.13 | $0.00 | +$0.13 | $245.9M | $249.03M | = | ![]() | ![]() | Details |



